Science | Nature | Cell | View More
Natural Products
Selumetinib (AZD6244)
Selumetinib (AZD6244)
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Selumetinib (AZD6244)
Price:
CAS No.: 606143-52-6
Catalog No.: CFN60042
Molecular Formula: C17H15BrClFN4O3
Molecular Weight: 457.68 g/mol
Purity: >=98%
Type of Compound: Alkaloids
Physical Desc.: Powder
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS
Similar structural: Comparison
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • Universidad de Buenos Aires (Argentina)
  • University of Maryland (USA)
  • Kazusa DNA Research Institute (Japan)
  • Aarhus University (Denmark)
  • Mahatma Gandhi University (India)
  • Auburn University (USA)
  • Instituto de Investigaciones Ag... (Chile)
  • Universidade Federal de Santa C... (Brazil)
  • University of Hawaii Cancer Center (USA)
  • University of Queensland (Australia)
  • Center for protein Engineering ... (Belgium)
  • More...
Package
Featured Products
Geniposide

Catalog No: CFN98261
CAS No: 24512-63-8
Price: $30/20mg
Triptolide

Catalog No: CFN99196
CAS No: 38748-32-2
Price: $118/20mg
Umbelliferone

Catalog No: CFN97503
CAS No: 93-35-6
Price: $30/20mg
Ginkgolide C

Catalog No: CFN99639
CAS No: 15291-76-6
Price: $30/20mg
Licochalcone D

Catalog No: CFN93186
CAS No: 144506-15-0
Price: $ / mg
Ginsenoside MC

Catalog No: CFN95232
CAS No: 175484-06-7
Price: $318/10mg
Alstonine

Catalog No: CFN97709
CAS No: 642-18-2
Price: $ /
Cannabidiolic acid

Catalog No: CFN99356
CAS No: 1244-58-2
Price: $413/5mg
Tetrahydroalstonine

Catalog No: CFN97109
CAS No: 6474-90-4
Price: $338/5mg
Ginkgolic acid C13:0

Catalog No: CFN98507
CAS No: 20261-38-5
Price: $168/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Selumetinib (AZD6244, ARRY-142886) is a potent, highly selective MEK inhibitor with IC50 of 14 nM for MEK1 and Kd value of 530 nM for MEK2. It also inhibits ERK1/2 phosphorylation with IC50 of 10 nM, no inhibition to p38α, MKK6, EGFR, ErbB2, ERK2, B-Raf, etc. Selumetinib suppresses cell proliferation, migration and trigger apoptosis.
Targets: MEK1/MEK2 | ERK1/2
In vitro:
Mol Cancer Ther,2010 Jul;9(7):1985-94.
Identification of common predictive markers of in vitro response to the Mek inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines.[Pubmed: 20587667]
Selumetinib (AZD6244; ARRY-142886) is a tight-binding, uncompetitive inhibitor of mitogen-activated protein kinase kinases (MEK) 1 and 2 currently in clinical development.
METHODS AND RESULTS:
We evaluated the effects of selumetinib in 31 human breast cancer cell lines and 43 human non-small cell lung cancer (NSCLC) cell lines to identify characteristics correlating with in vitro sensitivity to MEK inhibition. IC(50) <1 micromol/L (considered sensitive) was seen in 5 of 31 breast cancer cell lines and 15 of 43 NSCLC cell lines, with a correlation between sensitivity and raf mutations in breast cancer cell lines (P = 0.022) and ras mutations in NSCLC cell lines (P = 0.045). Evaluation of 27 of the NSCLC cell lines with Western blots showed no clear association between MEK and phosphoinositide 3-kinase pathway activation and sensitivity to MEK inhibition. Baseline gene expression profiles were generated for each cell line using Agilent gene expression arrays to identify additional predictive markers. Genes associated with differential sensitivity to selumetinib were seen in both histologies, including a small number of genes in which differential expression was common to both histologies.
CONCLUSIONS:
In total, these results suggest that clinical trials of selumetinib in breast cancer and NSCLC might select patients whose tumors harbor raf and ras mutations, respectively.
In vivo:
Clin Cancer Res,2007 Mar 1;13(5):1576-83.
Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor.[Pubmed: 17332304]
The Ras-Raf-mitogen-activated protein kinase kinase (MEK) pathway is overactive in many human cancers and is thus a target for novel therapeutics. We have developed a highly potent and selective inhibitor of MEK1/2. The purpose of these studies has been to show the biological efficacy of ARRY-142886 (AZD6244) in enzymatic, cellular, and animal models.
METHODS AND RESULTS:
The ability of ARRY-142886 to inhibit purified MEK1 as well as other kinases was evaluated. Its effects on extracellular signal-regulated kinase (ERK) phosphorylation and proliferation in several cell lines were also determined. Finally, the inhibitor was tested in HT-29 (colorectal) and BxPC3 (pancreatic) xenograft tumor models.The IC(50) of ARRY-142886 was determined to be 14 nmol/L against purified MEK1. This activity is not competitive with ATP, which is consistent with the high specificity of compound for MEK1/2. Basal and epidermal growth factor-induced ERK1/2 phosphorylation was inhibited in several cell lines as well as 12-O-tetradecanoylphorbol-13-acetate-induced ERK1/2 phosphorylation in isolated peripheral blood mononuclear cells. Treatment with ARRY-142886 resulted in the growth inhibition of several cell lines containing B-Raf and Ras mutations but had no effect on a normal fibroblast cell line. When dosed orally, ARRY-142886 was capable of inhibiting both ERK1/2 phosphorylation and growth of HT-29 xenograft tumors in nude mice. Tumor regressions were also seen in a BxPC3 xenograft model. In addition, tumors remained responsive to growth inhibition after a 7-day dosing holiday.
CONCLUSIONS:
ARRY-142886 is a potent and selective MEK1/2 inhibitor that is highly active in both in vitro and in vivo tumor models. This compound is currently being investigated in clinical studies.
Selumetinib (AZD6244) Description
Source:
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Theaflavanoside II

Catalog No: CFN95380
CAS No: 943785-09-9
Price: $318/5mg
Gossypetin 3-sophoroside-8-glucosi...

Catalog No: CFN95528
CAS No: 77306-93-5
Price: $318/5mg
Cannabisin B

Catalog No: CFN95268
CAS No: 144506-17-2
Price: $413/5mg
Gymnoside III

Catalog No: CFN95033
CAS No: 899430-03-6
Price: $238/10mg
Citrusin B

Catalog No: CFN95178
CAS No: 105279-10-5
Price: $388/5mg
Nardoaristolone B

Catalog No: CFN95203
CAS No: 1422517-82-5
Price: $398/5mg
Neoorthosiphol A

Catalog No: CFN95447
CAS No: 243448-72-8
Price: $318/10mg
Dioscoreside E

Catalog No: CFN95346
CAS No: 435321-73-6
Price: $318/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.1849 mL 10.9247 mL 21.8493 mL 43.6987 mL 54.6233 mL
5 mM 0.437 mL 2.1849 mL 4.3699 mL 8.7397 mL 10.9247 mL
10 mM 0.2185 mL 1.0925 mL 2.1849 mL 4.3699 mL 5.4623 mL
50 mM 0.0437 mL 0.2185 mL 0.437 mL 0.874 mL 1.0925 mL
100 mM 0.0218 mL 0.1092 mL 0.2185 mL 0.437 mL 0.5462 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Protocol
Cell Research:
Mol Cancer Ther,2007 Jan;6(1):138-46.
Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.[Pubmed: 17237274]
Cell lines: Primary HCC cell lines including 2-1318, 4-1318 and 26-1004 cells
Concentrations:  ~ 10 μM
Incubation Time: 24 or 48 hours
Method:
Cells are seeded at a density of 2.0 × 104. After 48 hours incubation, the cells are rinsed twice with culture media. Cells are treated with various concentrations of AZD6244 for 24 or 48 hours. Cell viability is determined by the 3-(4,5-dimethylthiazol-2y1)-2,5-diphenyltetrazolium bromide (MTT) assay. Cell proliferation is assayed using a bromodeoxyuridine kit.
Geniposide

Catalog No: CFN98261
CAS No: 24512-63-8
Price: $30/20mg
Triptolide

Catalog No: CFN99196
CAS No: 38748-32-2
Price: $118/20mg
Umbelliferone

Catalog No: CFN97503
CAS No: 93-35-6
Price: $30/20mg
Ginkgolide C

Catalog No: CFN99639
CAS No: 15291-76-6
Price: $30/20mg
Licochalcone D

Catalog No: CFN93186
CAS No: 144506-15-0
Price: $ / mg
Ginsenoside MC

Catalog No: CFN95232
CAS No: 175484-06-7
Price: $318/10mg
Alstonine

Catalog No: CFN97709
CAS No: 642-18-2
Price: $ /
Cannabidiolic acid

Catalog No: CFN99356
CAS No: 1244-58-2
Price: $413/5mg
Tetrahydroalstonine

Catalog No: CFN97109
CAS No: 6474-90-4
Price: $338/5mg
Ginkgolic acid C13:0

Catalog No: CFN98507
CAS No: 20261-38-5
Price: $168/20mg
Tags: buy Selumetinib (AZD6244) | Selumetinib (AZD6244) supplier | purchase Selumetinib (AZD6244) | Selumetinib (AZD6244) cost | Selumetinib (AZD6244) manufacturer | order Selumetinib (AZD6244) | Selumetinib (AZD6244) distributor
rights reserved | Tel: +86-27-84237683
E-mail:manager@chemfaces.com
payment